Trachoma: transmission, infection, and control

Area of Science:

• Ophthalmology
• Infectious Diseases
• Immunology

Background:

• Trachoma blindness is targeted for elimination by the WHO using mass antibiotic treatment and facial cleanliness.
• Community responses to mass treatment for trachoma are variable, with complex links between Chlamydia trachomatis infection and clinical disease.
• Understanding these variations is crucial for optimizing treatment efficacy against active trachoma and preventing blindness.

Purpose of the Study:

• To review the immunobiology of trachoma.
• To develop a conceptual model of disease pathogenesis.
• To integrate this model into a mathematical framework for explaining infection and disease distribution.

Main Methods:

• Review of trachoma immunobiology.
• Development of a conceptual model for disease pathogenesis.
• Mathematical modeling to explain age-related distributions of infection, bacterial load, and disease.

Main Results:

• The conceptual and mathematical model explains observed community distributions of infection, bacterial load, and disease with age.
• Discrepancies between model predictions and empirical data emphasize the role of individual heterogeneity in infection response.
• The study provides insights into disease transmission and pathogenesis relevant to trachoma control.

Conclusions:

• A conceptual model integrated with mathematical frameworks can explain trachoma infection and disease patterns.
• Individual variations in response to Chlamydia trachomatis infection are significant.
• Findings have implications for refining trachoma control strategies to maximize treatment impact and prevent blindness.